Diagnostics

New England Biolabs® Announces 2024 Passion in Science Awards® Recipients

Twelve scientists to be recognized for their inspiring achievements in science mentorship, environmental stewardship, humanitarian efforts and the arts. IPSWICH,…

4 months ago

Sequentify and Dexter Collaborate to Introduce Genomic Sequencing Solutions to the Romanian Market

REHOVOT, Israel, Sept. 5, 2024 /PRNewswire/ -- Sequentify has partnered with Dexter, a Romanian distributor, to bring Sequentify's InfiniSeq™ library…

4 months ago

SOPHiA GENETICS Announces Validation of Novel Clinical Trial Assay Together with Precision for Medicine at World Clinical Biomarkers & CDx 2024

The companies share how their collaboration enables clinical trial enrollment for a novel cancer therapy for oncogene amplified cancers in…

4 months ago

Exer AI Collaborates with Mayo Clinic to Advance Standard of Care for Hand and Wrist Disorders with AI

DENVER, Sept. 5, 2024 /PRNewswire/ -- Exer AI, a clinical AI company addressing musculoskeletal (MSK) and movement disorders, today announced a…

4 months ago

Lexaria Welcomes Industry Veteran as New CEO

Outgoing CEO, Chris Bunka, to remain on as Chairman of the Board of Directors and Executive Strategic Advisor KELOWNA, BC…

4 months ago

Zomedica Secures CE Mark for TRUVIEWTM Digital Microscope & Telepathology System, Expanding Global Market Opportunities

CE Mark approval opens European market for TRUVIEW system ANN ARBOR, MI / ACCESSWIRE / September 5, 2024 / Zomedica…

4 months ago

Spectral AI Awarded Additional Funding from Medical Technology Enterprise Consortium to Support Ongoing Development of DeepView SnapShot M®

Project Funding Exceeds $7.0 MillionDALLAS, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the…

4 months ago

Royal Society Hosts BioAro’s UK Launch in Partnership with Golden Helix Foundation to Enhance Genomic Medicine Education

NEW YORK, Sept. 4, 2024 /PRNewswire/ -- BioAro successfully launched its presence in the UK at the Royal Society on August 29th,…

4 months ago

Constantiam Biosciences Secures $2.05M Phase II SBIR Grant from NHGRI to Advance Functional Analysis Platform for Variants of Uncertain Significance (VUS)

HOUSTON, Sept. 4, 2024 /PRNewswire/ -- Constantiam Biosciences, a startup focused on powering genomic medicine, is pleased to announce that…

4 months ago

Biofidelity announces three senior leadership team appointments

Chief Operating Officer, Vice President of People and Chief Financial Officer will contribute to Biofidelity's growth and people priorities CAMBRIDGE,…

4 months ago